Követés
Mónika Katkó
Mónika Katkó
University of Debrecen, Faculty of Medicine
E-mail megerősítve itt: belklinika.com
Cím
Hivatkozott rá
Hivatkozott rá
Év
Hydrogen sulfide inhibits the calcification and osteoblastic differentiation of vascular smooth muscle cells
E Zavaczki, V Jeney, A Agarwal, A Zarjou, M Oros, M Katko, Z Varga, ...
Kidney international 80 (7), 731-739, 2011
1262011
New formulations of levothyroxine in the treatment of hypothyroidism: trick or treat?
EV Nagy, P Perros, E Papini, M Katko, L Hegedüs
Thyroid 31 (2), 193-201, 2021
582021
Simplifying complex insulin regimens while preserving good glycemic control in type 2 diabetes
Z Taybani, B Bótyik, M Katkó, A Gyimesi, T Várkonyi
Diabetes Therapy 10, 1869-1878, 2019
552019
Strong correlations between circulating chemerin levels and lipoprotein subfractions in nondiabetic obese and nonobese subjects
H Lőrincz, M Katkó, M Harangi, S Somodi, K Gaál, P Fülöp, G Paragh, ...
Clinical endocrinology 81 (3), 370-377, 2014
502014
Effects of tocopherols and 2, 2′-carboxyethyl hydroxychromans on phorbol-ester-stimulated neutrophils
Z Varga, E Kosaras, E Komodi, M Katko, I Karpati, J Balla, G Paragh, ...
The Journal of Nutritional Biochemistry 19 (5), 320-327, 2008
392008
Relationship between serum nickel and homocysteine concentration in hemodialysis patients
M Katko, I Kiss, I Karpati, A Kadar, J Matyus, E Csongradi, J Posta, ...
Biological trace element research 124, 195-205, 2008
352008
Thyroglobulin level at week 16 of pregnancy is superior to urinary iodine concentration in revealing preconceptual and first trimester iodine supply
M Katko, AA Gazso, I Hircsu, HP Bhattoa, Z Molnar, B Kovacs, D Andrasi, ...
Maternal & Child Nutrition 14 (1), e12470, 2018
282018
Paraoxonase-1 arylesterase activity is an independent predictor of myeloperoxidase levels in overweight patients with or without cardiovascular complications
N Zsíros, P Koncsos, H Lőrincz, I Seres, M Katkó, A Szentpéteri, VE Varga, ...
Clinical biochemistry 49 (12), 862-867, 2016
202016
Cell density-dependent stimulation of PAI-1 and hyaluronan synthesis by TGF-β in orbital fibroblasts
E Galgoczi, F Jeney, A Gazdag, A Erdei, M Katko, DM Nagy, B Ujhelyi, ...
J Endocrinol 229 (2), 187-96, 2016
202016
Cerebrotendinous xanthomatosis with the c. 379 C> T (p. R127 W) mutation in the CYP27A1 gene associated with premature age-associated limbic tauopathy.
I Kapás, M Katkó, M Harangi, G Paragh, I Balogh, Z Koczi, ...
Neuropathology & Applied Neurobiology 40 (3), 2014
182014
Lower educational status interferes with maternal iodine intake during both pregnancy and lactation
L Samson, I Hircsu, M Katko, M Bodor, A Gazdag, AA Gazso, B Kovacs, ...
Endocrine Connections 10 (7), 742-749, 2021
142021
Paraoxonase-1 and myeloperoxidase correlate with vascular biomarkers in overweight patients with newly diagnosed untreated hyperlipidaemia
A Szentpéteri, N Zsíros, VE Varga, H Lőrincz, M Katkó, I Seres, P Fülöp, ...
Vasa 46 (5), 370-376, 2017
122017
Different effects of cigarette smoke, heated tobacco product and e-cigarette vapour on orbital fibroblasts in graves’ orbitopathy; A study by real time cell electronic sensing
JK Aranyosi, E Galgoczi, A Erdei, M Katko, M Fodor, Z Ujhelyi, I Bacskay, ...
Molecules 27 (9), 3001, 2022
102022
Characteristics of hyaluronan synthesis inhibition by 4-methylumbelliferone in orbital fibroblasts
E Galgoczi, F Jeney, M Katko, A Erdei, A Gazdag, L Sira, M Bodor, E Berta, ...
Investigative Ophthalmology & Visual Science 61 (2), 27-27, 2020
102020
Effects of 1-year tofacitinib therapy on angiogenic biomarkers in rheumatoid arthritis
G Kerekes, M Czókolyová, A Hamar, A Pusztai, G Tajti, M Katkó, E Végh, ...
Rheumatology 62 (SI3), SI304-SI312, 2023
72023
Plasminogen activator inhibitor type 1: a possible novel biomarker of late pituitary dysfunction after mild traumatic brain injury
I Frendl, M Katko, E Galgoczi, J Boda, N Zsiros, Z Nemeti, Z Bereczky, ...
Journal of Neurotrauma 34 (23), 3238-3244, 2017
72017
Homocysteine metabolism in peripheral blood mononuclear cells: evidence for cystathionine beta-synthase activity in resting state
M Katko, E Zavaczki, V Jeney, G Paragh, J Balla, Z Varga
Amino Acids 43, 317-326, 2012
72012
One‐year safety and efficacy results of insulin treatment simplification with IDegLira in type 2 diabetes
ZJ Taybani, B Bótyik, A Gyimesi, M Katkó, T Várkonyi
Endocrinology, Diabetes & Metabolism 6 (1), e390, 2023
62023
Komplex inzulinkezelési rezsimek deeszkalációja a jó glikémiás kontroll megőrzésével 2-es típusú diabetes mellitusban [De-escalation of complex insulin regimens while …
ZJ Taybani, B Bótyik, M Katkó, A Gyimesi, P Kempler, T Várkonyi
Diabetologia Hungarica 28 (1), 33-42, 2020
62020
Advanced glycation end products and their soluble receptor (sRAGE) in patients with Hashimoto’s thyroiditis on levothyroxine substitution
S Csiha, I Molnar, S Halmi, D Hutkai, H Lőrincz, S Somodi, M Katko, ...
Frontiers in Endocrinology 14, 1187725, 2023
32023
A rendszer jelenleg nem tudja elvégezni a műveletet. Próbálkozzon újra később.
Cikkek 1–20